MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Albany Molecular Research Company Profile (NASDAQ:AMRI)

Consensus Ratings for Albany Molecular Research (NASDAQ:AMRI) (?)
Ratings Breakdown: 1 Sell Rating(s), 1 Hold Rating(s), 2 Buy Rating(s)
Consensus Rating:Hold (Score: 2.25)
Consensus Price Target: $18.67 (6.29% downside)

Analysts' Ratings History for Albany Molecular Research (NASDAQ:AMRI)
Show:
DateFirmActionRatingPrice TargetActions
2/13/2015Morgan StanleySet Price TargetBuy$19.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/18/2014First AnalysisInitiated CoverageEqual WeightView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/6/2014JPMorgan Chase & Co.Reiterated RatingOverweight$25.00 -> $22.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/9/2014JPMorgan Chase & Co.Initiated CoverageOverweight$25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/7/2014Morgan StanleyReiterated RatingUnderperform$13.00 -> $15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/7/2014Sterne Agee CRTReiterated RatingUnderperform$13.00 -> $15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/11/2014Morgan StanleyReiterated RatingOverweight$19.00 -> $21.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/9/2014Morgan StanleyInitiated CoverageOverweight$19.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/21/2014Sterne Agee CRTDowngradeNeutral -> UnderperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/3/2013Sterne Agee CRTDowngradeBuy -> Neutral$15.00 -> $12.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/13/2013Sterne Agee CRTLower Price TargetBuy$15.00 -> $14.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/5/2013 forward)